|  Help  |  About  |  Contact Us

Publication : Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1.

First Author  Abu-Abed S Year  2003
Journal  Development Volume  130
Issue  7 Pages  1449-59
PubMed ID  12588859 Mgi Jnum  J:81583
Mgi Id  MGI:2449670 Doi  10.1242/dev.00357
Citation  Abu-Abed S, et al. (2003) Developing with lethal RA levels: genetic ablation of Rarg can restore the viability of mice lacking Cyp26a1. Development 130(7):1449-59
abstractText  We have previously reported that the retinoic acid (RA) catabolizing enzyme CYP26A1 plays an important role in protecting tail bud tissues from inappropriate exposure to RA generated in the adjacent trunk tissues by RALDH2, and that Cyp26a1-null animals exhibit spina bifida and caudal agenesis. We now show that, in the absence of Cyp26a1, retinoic acid receptor gamma (RARgamma) mediates ectopic RA-signaling in the tail bud. We also show that activated RARgamma results in downregulation of Wnt3a and Fgf8, which integrate highly conserved signaling pathways known for their role in specifying caudal morphogenesis. Ablation of the gene for RARgamma (Rarg) rescues Cyp26a1-null mutant animals from caudal regression and embryonic lethality, thus demonstrating that CYP26A1 suppresses the RA-mediated downregulation of WNT3A and FGF8 signaling pathways by eliminating ectopic RA in gastrulating tail bud mesoderm.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

14 Bio Entities

Trail: Publication

73 Expression

Trail: Publication